Tudor Investment Corp
LEGN icon

Tudor Investment Corp’s Legend Biotech LEGN Stock Holding History

Tudor Investment Corp’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839K Sell
29,066
-26,036
-47% -$702K ﹤0.01% 2537
2026
Q1 		$997K Buy
55,102
+1,802
+3% +$34.4K ﹤0.01% 2376
2025
Q4 		$1.16M Buy
53,300
+628
+1% +$18K ﹤0.01% 2165
2025
Q3 		$1.72M Buy
52,672
+3,167
+6% +$117K ﹤0.01% 1902
2025
Q2 		$1.76M Sell
49,505
-22,555
-31% -$731K ﹤0.01% 1745
2025
Q1 		$2.44M Buy
+72,060
New +$2.58M 0.01% 1200
2024
Q4 		– Sell
-5,572
Closed -$231K – 3292
2024
Q3 		$272K Buy
+5,572
New +$297K ﹤0.01% 2373
2020
Q3 		– Sell
-8,771
Closed -$373K – 1435
2020
Q2 		$373K Buy
+8,771
New +$343K 0.02% 811

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Tudor Investment Corp's LEGN Position: Q2 2026 in Review

Tudor Investment Corp reduced its Legend Biotech (LEGN) stake by 47% in Q2 2026, selling an estimated $702K and leaving 29,066 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Tudor Investment Corp first reported a position in LEGN in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.44M in Q1 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Tudor Investment Corp held 29,066 shares of Legend Biotech worth $839K as of Q2 2026.
  • Tudor Investment Corp sold 26,036 Legend Biotech shares in Q2 2026, an estimated $702K.
  • Legend Biotech made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #2537 holding.
  • Tudor Investment Corp first reported a position in Legend Biotech in Q2 2020 and has held it in 8 quarters since.
  • Tudor Investment Corp's Legend Biotech position peaked at $2.44M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.